» Articles » PMID: 26497921

Should Prebiopsy Multiparametric Magnetic Resonance Imaging Be Offered to All Biopsy-naïve Men Undergoing Prostate Biopsy?

Overview
Journal Eur Urol
Specialty Urology
Date 2015 Oct 27
PMID 26497921
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Developing an effective strategy to improve the detection of significant prostate cancer by combining the 4Kscore and multiparametric MRI.

Marzouk K, Ehdaie B, Vertosick E, Zappala S, Vickers A Urol Oncol. 2019; 37(10):672-677.

PMID: 31378585 PMC: 6733611. DOI: 10.1016/j.urolonc.2019.07.010.


The Role of Tumor Oxygenation Tested by Magnetic Resonance Imaging (MRI) in Prostate Cancer Grading.

Geng H, Tong W, Han F, Zhu K, Cao Y, Chen X Med Sci Monit. 2019; 25:2505-2510.

PMID: 30950457 PMC: 6463617. DOI: 10.12659/MSM.913110.


Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy.

Zhou Y, Zhou Z, Li Q, Xu Y, Sun H, Xiao Y Medicine (Baltimore). 2018; 97(38):e12495.

PMID: 30235754 PMC: 6160219. DOI: 10.1097/MD.0000000000012495.


Multimodality Image Fusion with PSMA PET/CT and High-Intensity Focused Ultrasound Focal Therapy for Primary Diagnosis and Management of Prostate Cancer: A Planned Research Initiative.

Javitt M, Kravtsov A, Keidar Z, Abadi S, Amiel G Rambam Maimonides Med J. 2017; 8(4).

PMID: 28777073 PMC: 5652928. DOI: 10.5041/RMMJ.10312.


68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.

Zang S, Shao G, Cui C, Li T, Huang Y, Yao X Oncotarget. 2017; 8(7):12247-12258.

PMID: 28103574 PMC: 5355341. DOI: 10.18632/oncotarget.14691.